Impact of the sleep apnea management group clinic on positive airway pressure adherence.

Authors:
Tran K; Wang L; Mehra R; Vanek R; Kaw S and 4 more

Journal:
Sleep Breath

Publication Year: 2021

DOI:
10.1007/s11325-021-02352-w

PMCID:
PMC8084412

PMID:
33928484

Journal Information

Full Title: Sleep Breath

Abbreviation: Sleep Breath

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interest1. Katie Tran, M.D—no financial disclosures, no conflicts of interests2. Lu Wang, M.S—no financial disclosures, no conflicts of interests3. Reena Mehra, M.D, M.S—her institution has received positive airway pressure machines and equipment from Philips Respironics for use in NIH-funded research. She has received honorarium from the American Academy of Sleep Medicine for speaking4. Robon Vanek, R.N, A.N.P—no financial disclosures, no conflicts of interests5. Shivani Kaw—no financial disclosures, no conflicts of interests6. Douglas E Moul, M.D., M.P.H.—no financial disclosures, no conflicts of interests7. Tina Campean, R.N—no financial disclosures, no conflicts of interests8. Nancy Foldvary-Schaefer, D.O, M.S—is a consultant for Jazz Pharmaceuticals9. Harneet Walia, M.D—has received funding from Resmed for randomized controlled trial to assess the impact of sleep apnea management clinic in PAP adherence. She is the principal investigator of the studies with hypoglossal nerve stimulator. Ethics approval and consent to participateAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This was a retrospective study; informed consent was not obtained. Conflict of interest 1. Katie Tran, M.D—no financial disclosures, no conflicts of interests 2. Lu Wang, M.S—no financial disclosures, no conflicts of interests 3. Reena Mehra, M.D, M.S—her institution has received positive airway pressure machines and equipment from Philips Respironics for use in NIH-funded research. She has received honorarium from the American Academy of Sleep Medicine for speaking 4. Robon Vanek, R.N, A.N.P—no financial disclosures, no conflicts of interests 5. Shivani Kaw—no financial disclosures, no conflicts of interests 6. Douglas E Moul, M.D., M.P.H.—no financial disclosures, no conflicts of interests 7. Tina Campean, R.N—no financial disclosures, no conflicts of interests 8. Nancy Foldvary-Schaefer, D.O, M.S—is a consultant for Jazz Pharmaceuticals 9. Harneet Walia, M.D—has received funding from Resmed for randomized controlled trial to assess the impact of sleep apnea management clinic in PAP adherence. She is the principal investigator of the studies with hypoglossal nerve stimulator."

Evidence found in paper:

"Declarations: Conflict of interest1. Katie Tran, M.D—no financial disclosures, no conflicts of interests2. Lu Wang, M.S—no financial disclosures, no conflicts of interests3. Reena Mehra, M.D, M.S—her institution has received positive airway pressure machines and equipment from Philips Respironics for use in NIH-funded research. She has received honorarium from the American Academy of Sleep Medicine for speaking4. Robon Vanek, R.N, A.N.P—no financial disclosures, no conflicts of interests5. Shivani Kaw—no financial disclosures, no conflicts of interests6. Douglas E Moul, M.D., M.P.H.—no financial disclosures, no conflicts of interests7. Tina Campean, R.N—no financial disclosures, no conflicts of interests8. Nancy Foldvary-Schaefer, D.O, M.S—is a consultant for Jazz Pharmaceuticals9. Harneet Walia, M.D—has received funding from Resmed for randomized controlled trial to assess the impact of sleep apnea management clinic in PAP adherence. She is the principal investigator of the studies with hypoglossal nerve stimulator.: Ethics approval and consent to participateAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This was a retrospective study; informed consent was not obtained. Conflict of interest: 1. Katie Tran, M.D—no financial disclosures, no conflicts of interests: 2. Lu Wang, M.S—no financial disclosures, no conflicts of interests: 3. Reena Mehra, M.D, M.S—her institution has received positive airway pressure machines and equipment from Philips Respironics for use in NIH-funded research. She has received honorarium from the American Academy of Sleep Medicine for speaking: 4. Robon Vanek, R.N, A.N.P—no financial disclosures, no conflicts of interests: 5. Shivani Kaw—no financial disclosures, no conflicts of interests: 6. Douglas E Moul, M.D., M.P.H.—no financial disclosures, no conflicts of interests: 7. Tina Campean, R.N—no financial disclosures, no conflicts of interests: 8. Nancy Foldvary-Schaefer, D.O, M.S—is a consultant for Jazz Pharmaceuticals: 9. Harneet Walia, M.D—has received funding from Resmed for randomized controlled trial to assess the impact of sleep apnea management clinic in PAP adherence. She is the principal investigator of the studies with hypoglossal nerve stimulator."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025